Université Paris Cité, INSERM U970, Paris Institute for Transplantation and Organ Regeneration, Paris, France.
GenoSplice, Paris, France.
Transpl Int. 2024 Jul 10;37:13043. doi: 10.3389/ti.2024.13043. eCollection 2024.
Recently, interest in transcriptomic assessment of kidney biopsies has been growing. This study investigates the use of NGS to identify gene expression changes and analyse the pathways involved in rejection. An Illumina bulk RNA sequencing on the polyadenylated RNA of 770 kidney biopsies was conducted. Differentially-expressed genes (DEGs) were determined for AMR and TCMR using DESeq2. Genes were segregated according to their previous descriptions in known panels (microarray or the Banff Human Organ Transplant (B-HOT) panel) to obtain NGS-specific genes. Pathway enrichment analysis was performed using the Reactome and Kyoto Encyclopaedia of Genes and Genomes (KEGG) public repositories. The differential gene expression using NGS analysis identified 6,141 and 8,478 transcripts associated with AMR and TCMR. While most of the genes identified were included in the microarray and the B-HOT panels, NGS analysis identified 603 (9.8%) and 1,186 (14%) new specific genes. Pathways analysis showed that the B-HOT panel was associated with the main immunological processes involved during AMR and TCMR. The microarrays specifically integrated metabolic functions and cell cycle progression processes. Novel NGS-specific based transcripts associated with AMR and TCMR were discovered, which might represent a novel source of targets for drug designing and repurposing.
最近,人们对肾活检的转录组评估越来越感兴趣。本研究利用 NGS 来鉴定基因表达变化,并分析排斥反应涉及的途径。对 770 个肾活检的多聚腺苷酸化 RNA 进行了 Illumina 批量 RNA 测序。使用 DESeq2 确定 AMR 和 TCMR 的差异表达基因(DEGs)。根据已知面板(微阵列或 Banff 人类器官移植(B-HOT)面板)中这些基因的先前描述对基因进行分类,以获得 NGS 特异性基因。使用 Reactome 和京都基因与基因组百科全书(KEGG)公共存储库进行通路富集分析。使用 NGS 分析的差异基因表达鉴定出与 AMR 和 TCMR 相关的 6,141 个和 8,478 个转录本。虽然大多数鉴定的基因都包含在微阵列和 B-HOT 面板中,但 NGS 分析鉴定出 603(9.8%)和 1,186(14%)个新的特异性基因。通路分析表明,B-HOT 面板与 AMR 和 TCMR 期间涉及的主要免疫过程相关。微阵列特别整合了代谢功能和细胞周期进程。发现与 AMR 和 TCMR 相关的新型 NGS 特异性转录本,这可能代表药物设计和重新利用的新靶点来源。